首页|期刊导航|Food Science and Human Wellness|Tetramethylpyrazine and paeoniflorin combination(TMP-PF)alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway
Tetramethylpyrazine and paeoniflorin combination(TMP-PF)alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway
Rong Yuan Qiqi Xin Weili Shi Yu Miao Zhengchuan Zhu Yahui Yuan Ying Chen Xiaoning Chen Sean Xiao Leng Keji Chen Weihong Cong
Food Science and Human Wellness2024,Vol.13Issue(5):P.2642-2652,11.
Food Science and Human Wellness2024,Vol.13Issue(5):P.2642-2652,11.DOI:10.26599/FSHW.2022.9250212
Tetramethylpyrazine and paeoniflorin combination(TMP-PF)alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway
摘要
关键词
Atherosclerosis/Hyperlipemia/Angiogenesis/Plaque stability/Chinese medicine/Tetramethylpyrazine/Paeoniflorin分类
医药卫生引用本文复制引用
Rong Yuan,Qiqi Xin,Weili Shi,Yu Miao,Zhengchuan Zhu,Yahui Yuan,Ying Chen,Xiaoning Chen,Sean Xiao Leng,Keji Chen,Weihong Cong..Tetramethylpyrazine and paeoniflorin combination(TMP-PF)alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway[J].Food Science and Human Wellness,2024,13(5):P.2642-2652,11.基金项目
supported by Fundamental Research Funds for the Central Public Welfare Research Institutes(ZZ11-061,ZZ14-YQ-007) (ZZ11-061,ZZ14-YQ-007)
the National Natural Science Foundation of China(82004193) (82004193)
CACMS Innovation Fund(CI 2021A00914) (CI 2021A00914)
Irma and Paul Milstein Program for Senior Health of Milstein Medical Asian American Partnership Foundation。 ()